dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer

OBJECTIVES: Decreased deoxycytidine kinase (dCK) expression is a reported indicator of gemcitabine efficacy in pancreatic cancer, due to the impact of this kinase on gemcitabine metabolism. The transcription factor NF‐E2 p45‐related factor 2 (NRF2, also called Nfe2l2), a master regulator of redox ho...

詳細記述

保存先:
書誌詳細
出版年:Cell Prolif
主要な著者: Hu, Qiangsheng, Qin, Yi, Xiang, Jinfeng, Liu, Wensheng, Xu, Wenyan, Sun, Qiqing, Ji, Shunrong, Liu, Jiang, Zhang, Zheng, Ni, Quanxing, Xu, Jin, Yu, Xianjun, Zhang, Bo
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2018
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528851/
https://ncbi.nlm.nih.gov/pubmed/29701272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12456
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料